Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

George Jenkins sits in Covington’s Band 1 ranked Life Sciences Transactions team, specializing in advising life sciences and digital health clients on complex, strategic commercial agreements. In particular, he advises clients on structuring, negotiating and drafting their collaborations, joint ventures, IP licensing, co-development arrangements, and agreements for the manufacture, distribution, and supply of goods. Mr. Jenkins also regularly works closely with the firm's Corporate Practice Group on product divestments, asset transfers, and related transitional agreements.

  • Advising on the commercial agreements in relation to a global pharmaceutical company's acquisition of a significant oncology business and the related joint venture.        
  • Advising on the commercial aspects and supply arrangements for an international pharmaceutical group's acquisition of a portfolio of a multinational pharmaceutical and biopharmaceutical company's pharmaceutical products.  
  • Advising an EU-based pharmaceutical company on the commercial and transitional aspects of its ex-U.S. closing of its oncology business sale.
  • Advising a major multi-national pharmaceutical company on a range of strategic relationships and commercial arrangements, including a number of long term collaboration, licensing and supply agreements.
  • Advising one of the world's largest pharmaceutical companies on strategic licensing and collaboration arrangements with a UK biotechnology firm.

  • Advising on the divestment of a mature prescription product of a global pharmaceutical company and associated licensing, manufacturing and distribution arrangements.
  • Advising a global digital venture company on their agreements with a leading pharmaceutical company for the development of digital health products.
  • Advising a major U.S. pharmaceutical company on its EU expansion, including on commercial structures and licensing requirements.
  • Advising a Dutch beverage company on the licensing and commercial arrangements for its innovative manufacturing technology.
  • Advising a global commodities company on procurement and supply arrangements for the supply of pharmaceutical products into Africa and on related supply chain structural considerations, including applicable regulatory and licensing requirements.
  • Advising a leading international company on establishing and negotiating the commercial arrangements for its digital, wearable technology products.

Pro Bono

  • A leading British sporting charitable association on a number of commercial agreements.   
  • Advising a sustainable food brand on agreements for the manufacture and supply of products from ingredients that would otherwise go to waste.